Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CASH
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Elizabeth G. Hoople Director | CASH Pathward Financial, Inc. | Sale | 4,500 | $82.29 | $370.3K Sale | Form 4 ↗ |
| Apr 29, 2026 | Douglas J. Hajek Director | CASH Pathward Financial, Inc. | Sale | 5,000 | $86.37 | $431.9K Sale | Form 4 ↗ |
| Feb 23, 2026 | Brett L. Pharr Chief Executive Officer, Director | CASH Pathward Financial, Inc. | Sale | 15,641 | $93.88 | $1.5M Sale | Form 4 ↗ |
| Feb 9, 2026 | Kendall E. Stork Director | CASH Pathward Financial, Inc. | Sale | 3,000 | $94.15 | $282.4K Sale | Form 4 ↗ |
| Jan 30, 2026 | Christopher Perretta Director | CASH Pathward Financial, Inc. | Sale | 1,450 | $89.94 | $130.4K Sale | Form 4 ↗ |
| Oct 31, 2025 | Douglas J. Hajek Director | CASH Pathward Financial, Inc. | Sale | 3,000 | $68.11 | $204.3K Sale | Form 4 ↗ |
| Oct 28, 2025 | Neeraj Mehta Director | CASH Pathward Financial, Inc. | Sale | 2,500 | $69.34 | $173.3K Sale | Form 4 ↗ |
| Oct 24, 2025 | Nadia Dombrowski Chief Legal and Admin Officer | CASH Pathward Financial, Inc. | Sale | 5,000 | $71.46 | $357.3K Sale | Form 4 ↗ |
| Oct 24, 2025 | Anthony M. Sharett President | CASH Pathward Financial, Inc. | Sale | 11,500 | $71.55 | $822.8K Sale | Form 4 ↗ |
| Apr 29, 2025 | Kendall E. Stork Director | CASH Pathward Financial, Inc. | Sale | 4,000 | $79.33 | $317.3K Sale | Form 4 ↗ |
| Apr 25, 2025 | Jennifer W. Warren SVP, Chief Accounting Officer | CASH Pathward Financial, Inc. | Sale | 1,667 | $77.97 | $130.0K Sale | Form 4 ↗ |
| Apr 25, 2025 | Brett L. Pharr Chief Executive Officer, Director | CASH Pathward Financial, Inc. | Sale | 10,365 | $78.07 | $809.2K Sale | Form 4 ↗ |
| Apr 25, 2025 | Douglas J. Hajek Director | CASH Pathward Financial, Inc. | Sale | 1,850 | $79.26 | $146.6K Sale | Form 4 ↗ |
| Nov 8, 2024 | Greg Sigrist Chief Financial Officer | CASH Pathward Financial, Inc. | Sale | 2,250 | $80.60 | $181.3K Sale | Form 4 ↗ |
| Nov 6, 2024 | Jennifer W. Warren SVP, Chief Accounting Officer | CASH Pathward Financial, Inc. | Sale | 1,556 | $79.15 | $123.2K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:41 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances